119 filings
Page 2 of 6
8-K
q8icq l86xpq
22 May 23
Oncorus Reports First Quarter 2023 Financial Results and Provides Business Updates
4:13pm
8-K
tg3315xdd3 ud4q6o
18 May 23
Termination of a Material Definitive Agreement
4:06pm
NT 10-Q
8xt89e 0thfg0
16 May 23
Notice of late quarterly filing
4:37pm
8-K
kya258hls18 94
5 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:02pm
8-K
petyt3
1 May 23
Departure of Directors or Certain Officers
6:39am
S-8
xkhy2g5u 91cvp3m
24 Mar 23
Registration of securities for employees
4:40pm
8-K
irs61 d5p
24 Mar 23
Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
7:27am
8-K
czyp58qt
14 Mar 23
Regulation FD Disclosure
4:28pm
8-K
oaxhkbgy
10 Mar 23
Regulation FD Disclosure
5:09pm
8-K
tjva4 izausku
30 Nov 22
Oncorus Announces Portfolio Reprioritization to Focus on IV-Administered, Self-Amplifying RNA Medicines for Patients with Cancer
7:07am
8-K
vn0r l2ii274nu
2 Nov 22
Oncorus Reports Third Quarter 2022 Financial Results and Provides Business Updates
7:11am
8-K
n09ei09gfqykiwal4
14 Sep 22
Entry into a Material Definitive Agreement
4:34pm
8-K
x56bmfuq
5 Aug 22
Regulation FD Disclosure
7:10am
8-K
qxkcf4vlwrf yuga2yzw
4 Aug 22
Oncorus Reports Second Quarter 2022 Financial Results and Provides Business Updates
9:04am
8-K
1p61ek 42dglf02ter9
23 Jun 22
Oncorus Appoints Douglas Fambrough to Board of Directors
7:21am